HLA-DR3 ~ DQ2 associates with sensory neuropathy in paraneoplastic neurological syndromes with Hu antibodies. [PDF]
Muñiz-Castrillo S +8 more
europepmc +1 more source
Paraneoplastic Neurological Syndromes as Initial Presentation of Tumors: An Eight-Year Single-Center Experience. [PDF]
Melanis K +14 more
europepmc +1 more source
Significant improvement in paraneoplastic neurological syndromes without identifiable anti-neural antibodies in patients with breast cancer after breast surgery. [PDF]
Oshino T +9 more
europepmc +1 more source
Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes. [PDF]
van Coevorden-Hameete MH +12 more
europepmc +1 more source
Various clinical features of patients with anti-Hu associated paraneoplastic neurological syndromes: An observational study. [PDF]
Li J, Lin W.
europepmc +1 more source
Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies. [PDF]
Berzero G +14 more
europepmc +1 more source
Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events. [PDF]
Seki T +10 more
europepmc +1 more source
Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies. [PDF]
Ariño H +12 more
europepmc +1 more source
The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes. [PDF]
Michalak S +4 more
europepmc +1 more source

